Masimo | MASI - Los Gastos De Explotación

Precio De Mercado
175.47
Cambio Diario
-0.02 -0.01%
Mensual
0.45%
Anual
1.56%
Q1 Expectativa
170.19




Los Gastos De Explotación Cambio Fecha
Abbott USD 9.21B 17M 2025-12
Accuray USD 37.18M 567K 2024-12
Align Technology USD 822.85M 11.8M 2025-12
AngioDynamics USD 81.98M 1.96M 2025-02
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
General Electric Aerospace USD 10.94B 7.87B 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Orthofix International USD 10.89M 209.57M 2024-09
Owens Minor USD -429.51M 1.05B 2025-09
ResMed USD 925.21M 51.98M 2025-12
Steris USD 1.22B 28.8M 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12